The UT Horizon Fund is the strategic venture fund of the University of Texas System.
Our dual mission is to improve commercialization of technologies out of research at UT System institutions (strategic goal) and provide a positive return on investment (financial goal).
Expanding the Horizon
Start-Up Company Cardiovate Signs Patent & License Agreement For TESAR, Hires New CEOTwo years after its launch, start-up biotechnology company Cardiovate has acquired a patent and technology license agreement with the University of Texas at San Antonio (UTSA) and the University of Texas Health Science Center (UTHSC). Cardiovate will now be able …Read More